Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 29,000 shares at $45.57 ($1.3M) on 2020-12-02, disclosed to the SEC on 2020-12-03.
Open-market sale of $1.3M PHAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.99 | 5,370 | $236K | 18.2% |
| 2 | $43.99 | 5,370 | $236K | 18.2% |
| 3 | $44.83 | 1,828 | $82K | 6.3% |
| 4 | $44.83 | 1,828 | $82K | 6.3% |
| 5 | $45.05 | 4,307 | $194K | 15.0% |
| 6 | $45.05 | 4,307 |
| $194K |
| 15.0% |
| 7 | $45.57 | 2,995 | $136K | 10.5% |
| 8 | $45.57 | 2,995 | $136K | 10.5% |
| Total | $44.74 avg | 29,000 | $1.3M | 100% |
| Filing → |
| PHAT | SELL | 2024-07-17 | $256K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |